Fisher & Paykel Healthcare (ASX:FPH) Cash Flow from Operations: A$567 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:FPH Fisher & Paykel Healthcare Corp Ltd ASX:FPH
88 GF Score
Price A$34.02
GF Value A$36.76
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Cash Flow from Operations?

Fisher & Paykel Healthcare ASX:FPH -0.64% 88 Cash Flow from Operations is A$567 Mil as of Mar. 2026. GuruFocus rates ASX:FPH with a GF Score™ of 88/100 and a GF Value™ of A$36.76 (Fairly Valued). The stock has 2 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Mar. 2026, Fisher & Paykel Healthcare's Cash Receipts from Operating Activities was A$997 Mil. Its Cash Payments was A$-612 Mil. Its Dividends Paid was A$0 Mil. Its Dividends Received was A$0 Mil. Its Interest Paid was A$-6 Mil. Its Interest Received was A$3 Mil. Its Taxes Refund Paid was A$-35 Mil. And its Cash Flow from Others was A$-0 Mil. In all, Fisher & Paykel Healthcare's Cash Flow from Operations for the six months ended in Mar. 2026 was A$348 Mil.


Fisher & Paykel Healthcare  (ASX:FPH) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Fisher & Paykel Healthcare's cash receipts from operating activities for the six months ended in Mar. 2026 was A$997 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$-612 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$0 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$0 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$-6 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$3 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Fisher & Paykel Healthcare's cash payments for the six months ended in Mar. 2026 was A$-35 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Fisher & Paykel Healthcare's cash flow from others for the six months ended in Mar. 2026 was A$-0 Mil.


Fisher & Paykel Healthcare Cash Flow from Operations Related Terms


Fisher & Paykel Healthcare Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Cash Flow from Operations Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 302.03 221.49 398.50 498.64 552.67

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 253.33 214.15 286.86 219.20 347.83
ASX:FPH
88GF Score
Fisher & Paykel Healthcare Corp Ltd ASX:FPH
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Fisher & Paykel Healthcare's Cash Flow from Operations for the fiscal year that ended in Mar. 2026 is calculated as:

Fisher & Paykel Healthcare's Cash Flow from Operations for the quarter that ended in Mar. 2026 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$567 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of A$567 Mil mean?
Fisher & Paykel Healthcare (ASX:FPH) has a Cash Flow from Operations of A$567 Mil as of Mar. 2026. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's Cash Flow from Operations too high?
Fisher & Paykel Healthcare's current Cash Flow from Operations is A$567 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Cash Flow from Operations compare to ISRG and BDX?
Fisher & Paykel Healthcare's Cash Flow from Operations of A$567 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Medical Devices & Instruments company?
A good Cash Flow from Operations depends on the Medical Devices & Instruments industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current Cash Flow from Operations is A$567 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Fairly Valued. The stock's GF Value™ is A$36.76, compared to a current price of A$34.02 — trading 7.5% below its estimated fair value. The current Cash Flow from Operations is A$567 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current Cash Flow from Operations is A$567 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of A$34.02 is trading 7.5% below its estimated GF Value™ of A$36.76. GuruFocus considers Fisher & Paykel Healthcare to be Fairly Valued.

Key valuation signals for ASX:FPH:

  • Cash Flow from Operations: A$567 Mil
  • GF Value™: A$36.76 vs. price of A$34.02 (7.5% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fisher & Paykel Healthcare Business Description

Other Exchanges FSPKF:USAFPH:New Zealand
Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
88GF Score

Get the complete analysis for ASX:FPH

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$34.02
Price
A$36.76
GF Value